JAMA Oncology : Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
24.10.2024
0:00
20:41
Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.
Related Content:
Weitere Episoden von „JAMA Network“
Verpasse keine Episode von “JAMA Network” und abonniere ihn in der kostenlosen GetPodcast App.